Filters
Short-term treatment (6 weeks) with 10 mg prednisolone effectively reduces finger pain and improves function in patients who have painful hand osteoarthritis (OA) coupled with signs of inflammation, the HOPE* study has shown.
Being overweight or obese in adolescence appears to increase the risk of papillary thyroid cancer in adulthood, a recent study has shown.
The coronavirus has been spreading at a frantic pace, isolating families and snuffing out lives. As hunger and emotional contagion grip the nations, the hope of a containment also dims. No one has seen this enemy coming – the world has underestimated COVID-19.
Dr Poon Shi Hui, a consultant at the Department of Psychiatry at Singapore General Hospital, speaks to Roshini Claire Anthony on the different types of insomnia and the various management strategies deployed for each type.
Knee osteoarthritis (OA), whether symptomatic or radiographic, contributes to an increased risk of all-cause mortality, with the risk increase from symptomatic knee OA partially attributed to its effect on disability and quality of life (QoL).
Higher intakes of tofu, soy protein and soy isoflavones, but not total legumes or total soy, appear to reduce the risk of developing type 2 diabetes (T2D), suggests a study.
Treatment with delgocitinib 0.5% ointment leads to clinical improvements in adult patients with moderate-to-severe atopic dermatitis (AD) for up to 28 weeks, according to a Japan study.
Ophthalmologists are advised to cooperate with local infection control teams in the implementation of infection control measures that are appropriate for their clinical settings in order to minimize the transmission of coronavirus disease 2019 (COVID-19), suggests a Hong Kong study.
Higher dietary protein intake was associated with a lower risk of developing atrial fibrillation (AF) in postmenopausal women compared with lower protein intake, according to a secondary analysis presented at the ACC.20/WCC Virtual Meeting.
A long-acting (LA) injectable therapeutic regimen comprising the integrase strand-transfer inhibitor cabotegravir and the nonnucleoside reverse-transcriptase inhibitor rilpivirine shows therapeutic potential over an oral antiretroviral therapy (ART) regimen in adults with HIV-1, according to the week 96 results of the phase III FLAIR* trial.
